Optimized tDCS for Fibromyalgia: Targeting the Endogenous Pain Control System

NAActive, not recruitingINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

September 26, 2024

Study Completion Date

September 25, 2025

Conditions
Fibromyalgia
Interventions
DEVICE

Active tDCS

Active tDCS: A 1x1 Low-intensity DC Stimulator will be used to deliver direct current through rubber electrodes in saline soaked sponges. The anode will be placed over the left primary motor cortex (M1) while the cathode will be placed over the contralateral supra-orbital area. 20 minutes of tDCS will be applied.

PROCEDURE

Active Exercise

Participants will walk briskly in a treadmill (as to keep at 60-70% maximum heart rate) for 30 minutes

DEVICE

Sham tDCS

Active tDCS: A 1x1 Low-intensity DC Stimulator will be used to deliver direct current through rubber electrodes in saline soaked sponges. The anode will be placed over the left primary motor cortex (M1) while the cathode will be placed over the contralateral supra-orbital area. Only 30 seconds of current will be applied for the sham condition.

PROCEDURE

Sham Exercise

Participants will walk in a treadmill (as to keep at 10% within their baseline heart rate) for 30 minutes.

Trial Locations (1)

02138

Spaulding Rehabilitation Hospital for Continuing Care, Cambridge

All Listed Sponsors
lead

Spaulding Rehabilitation Hospital

OTHER

NCT03371225 - Optimized tDCS for Fibromyalgia: Targeting the Endogenous Pain Control System | Biotech Hunter | Biotech Hunter